The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers

Anxiety is highly prevalent in Alzheimer's disease (AD), correlating with cerebrospinal fluid/positron emission tomography biomarkers and disease progression. Relationships to plasma biomarkers are unclear. Herein, we compare levels of plasma biomarkers in research participants with and without anxiety at cognitively normal, mild cognitive impairment, and AD dementia stages. We observed significantly higher plasma tau/amyloid-β<sub>42</sub> ratio in AD participants with anxiety versus those without, but did not observe differences at other stages or plasma biomarkers. No such relationships were evident with depression. These results support a unique pathophysiological relationship between anxiety and AD that can be reflected in plasma biomarkers, suggestive of heightened neurodegeneration.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2024-11-27
DOI
https://doi.org/10.1177/13872877241295324
Citations
1
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers

Arjun V. Masurkar, Ricardo S. Osorio, Carolina Boza-Calvo, Alok Vedvyas et al.
1 citations
Journal of Alzheimer s Disease
Dementia and Cognitive Impairment Research
0.39
article

The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers

Arjun V. Masurkar, Ricardo S. Osorio, Carolina Boza-Calvo, Alok Vedvyas, Anthony Briggs, Mark A Bernard, Thomas Wısnıewskı, Karyn Marsh, Omonigho M. Bubu, Ludovic Debure, Wajiha Ahmed, Allal Boutajangout
article en
1 citations

Abstract

Anxiety is highly prevalent in Alzheimer's disease (AD), correlating with cerebrospinal fluid/positron emission tomography biomarkers and disease progression. Relationships to plasma biomarkers are unclear. Herein, we compare levels of plasma biomarkers in research participants with and without anxiety at cognitively normal, mild cognitive impairment, and AD dementia stages. We observed significantly higher plasma tau/amyloid-β<sub>42</sub> ratio in AD participants with anxiety versus those without, but did not observe differences at other stages or plasma biomarkers. No such relationships were evident with depression. These results support a unique pathophysiological relationship between anxiety and AD that can be reflected in plasma biomarkers, suggestive of heightened neurodegeneration.

Journal of Alzheimer s DiseaseVol. 102(4)
Universidad de Costa Rica (CR), Center for Neuro-Oncology (US), New York University (US)
Alzheimer's Association, BrightFocus Foundation, American Academy of Sleep Medicine, National Institutes of Health, National Institute on Aging
Good health and well-being
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers — Arjun V. Masurkar, Ricardo S. Osorio, et al. · Journal of Alzheimer s Disease (2024) | TGRS Research Map | TGRS